Status:
UNKNOWN
Circulating Endothelial Progenitor Cells and Aortic Aneurysm
Lead Sponsor:
Hopital Jean Minjoz
Conditions:
- Aortic Aneurysm
Eligibility:
All Genders
18-85 years
Brief Summary
We aimed to see if aortic aneurysms could be followed-up by circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- blood level.
Detailed Description
Circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14- have been shown to be inversely correlated to aortic aneurysm size. We aimed to see if aortic aneurysms could be followed...
Eligibility Criteria
Inclusion
- Aortic aneurysm size \>30mm and \> 50mm
Exclusion
- Infectious disease
- Inflammatory disease
- Liver insuffisency
- Cancer evolutive
- Pregnant women
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01918982
Start Date
October 1 2013
End Date
May 1 2016
Last Update
August 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.